Foghorn Therapeutics (FHTX) stock forecast for 2026. Forecast tables and graphs.







Top 5 Coins for the Maximum Passive Income from Staking by 2024

February 5, 2025 Top 5 Coins for the Maximum Passive Income from Staking by 2024

Staking is one of the ways that is now being used as a secure and profitable way to earn money without doing anything…
Trading Stocks With AI: A Modern Approach

January 21, 2025 Trading Stocks With AI: A Modern Approach

The stock market can feel overwhelming, especially with its constant ups and downs. Trading stocks with AI is revolutionizing how investors analyze trends,…
Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

January 21, 2025 Bitcoin Is Great, but Here Are 3 Altcoins Worth Considering in 2025

The launch of spot Bitcoin (CRYPTO: BTC) exchange-traded funds (ETFs) in January 2025 marked a turning point in the cryptocurrency market. These ETFs…
Advanced Charting Tools For Traders

January 1, 2025 Advanced Charting Tools For Traders

Ever tried deciphering market trends with the intensity of a detective peering over cryptic clues? Enter the realm of Advanced Charting, where complex…
Why Is Trading Important?

December 21, 2024 Why Is Trading Important?

Trade isn’t just figures on a spreadsheet; it’s the pulse of our global community. In 2018, the United States faced a staggering $621…

Foghorn Therapeutics (FHTX) stock forecast for 2026

Updated: February 16, 2025 (21:36)

Sector: Healthcare

The share price of Foghorn Therapeutics Inc. (FHTX) now

What analysts predict: $11.71
52-week High/Low: $10.25 / $3.86

50/200 Day Moving Average: $5.0 / $6.54

This figure corresponds to the Average Price over the previous 50/200 days. For Foghorn Therapeutics stocks, the 50-day moving average is the resistance level today.

For Foghorn Therapeutics stocks, the 200-day moving average is the resistance level today.

Are you interested in Foghorn Therapeutics Inc. stocks and want to buy them, or are they already in your portfolio? If yes, then on this page you will find useful information about the dynamics of the Foghorn Therapeutics stock price in 2026. How much will one Foghorn Therapeutics share be worth in 2026? Is it worth taking profit / loss on FHTX stock now or waiting? What are analysts' forecasts for Foghorn Therapeutics stock?

We forecast Foghorn Therapeutics stock performance using neural networks based on historical data on FHTX stocks. Also, when forecasting, technical analysis tools are used, world geopolitical and news factors are taken into account. This corporation stock prediction results are shown below and presented as a graph, table and text information.

Foghorn Therapeutics Inc. stock forecasts are adjusted once a day based on the closing price of the previous trading day.

The minimum target price for Foghorn Therapeutics analysts is $11.71. Today 200 Day Moving Average is the resistance level (6.54 $). 50 Day Moving Average is the resistance level (5.0 $).




Historical and forecast chart of Foghorn Therapeutics Inc. stock

The chart below shows the historical price of Foghorn Therapeutics stock and a prediction chart for the next year. For convenience, prices are divided by color. Forecast prices include: Optimistic Forecast, Pessimistic Forecast, and Weighted Average Best Forecast. Detailed values for the FHTX stock price can be found in the table below.


Foghorn Therapeutics Inc. focuses on the discovery and development of drugs targeting genetically determined addictions in the chromatin regulatory system. The Company’s gene traffic management platform enables it to identify, validate and potentially use drug targets in the chromatin regulatory system. It is initially focused on oncology. The company is developing FHD-286, a selective allosteric ATPase inhibitor, and FHD-609, a protein breaker, for the treatment of hematologic cancers and solid tumors. FHD-286 is an allosteric and orally available, small molecule, enzymatic inhibitor of BRG1 and BRM, which is initially being developed for the treatment of acute myeloid leukemia (AML) and uveal melanoma. FHD-609 is an intravenous, small molecule protein breaker BRD9. The company is also developing complementary programs for large populations, which include selective BRM and selective ARID1B modulators.

Trending Themes in the Healthcare Sector

Foghorn Therapeutics (FHTX) Forecast for 2026

Month Target Pes. Opt. Vol., %
Jan 2.70 1.75 3.12 43.94 %
Feb 1.66 1.08 2.23 51.44 %
Mar 1.68 1.31 2.29 42.99 %
Apr 2.07 1.67 2.38 29.82 %
May 2.88 1.79 3.46 48.09 %
Jun 3.11 2.30 4.04 43.00 %
Jul 2.54 2.17 3.26 33.61 %
Aug 3.57 2.47 4.90 49.70 %
Sep 4.95 3.28 6.00 45.39 %
Oct 2.93 2.29 3.33 31.02 %
Nov 2.67 2.35 3.04 22.66 %
Dec 2.98 2.25 3.59 37.39 %

Foghorn Therapeutics information and performance

Foghorn Therapeutics Address

500 TECHNOLOGY SQUARE, SUITE 700, CAMBRIDGE, MA, US

Market Capitalization: 340 903 000 $

Market capitalization of the Foghorn Therapeutics Inc. is the total market value of all issued shares of a company. It is calculated by the formula multiplying the number of FHTX shares in the company outstanding by the market price of one share.

EBITDA: -98 527 000 $

EBITDA of Foghorn Therapeutics is earnings before interest, income tax and depreciation of assets.

PE Ratio: None

P/E ratio (price to earnings) - shows the ratio between the price of a share and the company's profit

PEG Ratio: None

Price/earnings to growth

DPS: None

Dividend Per Share is a financial indicator equal to the ratio of the company's net profit available for distribution to the annual average of ordinary shares.

DY: None

Dividend yield is a ratio that shows how much a company pays in dividends each year at the stock price.

EPS: -1.85

EPS shows how much of the net profit is accounted for by the common share.

Quarterly Earnings Growth YOY: N/A
Quarterly Revenue Growth YOY: -0.553
Trailing PE: -

Trailing P/E depends on what has already been done. It uses the current share price and divides it by the total earnings per share for the last 12 months.

Forward PE: -

Forward P/E uses projections of future earnings instead of final numbers.

EV To Revenue: 4.412

Enterprise Value (EV) /Revenue

EV To EBITDA: -1.214

The EV / EBITDA ratio shows the ratio of the cost (EV) to its profit before tax, interest and amortization (EBITDA).

Shares Outstanding: 55612000

Number of issued ordinary shares

Shares Float: N/A

Number of freely tradable shares

Shares Short Prior Month: N/A

Shares Short Prior Month - the number of shares in short positions in the last month.

Short Ratio: N/A
Percent Insiders: N/A
Percent Institutions: N/A

Foghorn Therapeutics price target for 2026 by month


Target values for the price of one Foghorn Therapeutics share for Jan 2026.

The weighted average target price per Foghorn Therapeutics share in Jan 2026 is: 2.70.
In Jan, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 43.944% volatility is expected.
Pessimistic target level: 1.75
Optimistic target level: 3.12

Target values for the price of one Foghorn Therapeutics share for Feb 2026.

The weighted average target price per Foghorn Therapeutics share in Feb 2026 is: 1.66.
In Feb, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 51.441% volatility is expected.
Pessimistic target level: 1.08
Optimistic target level: 2.23

Target values for the price of one Foghorn Therapeutics share for Mar 2026.

The weighted average target price per Foghorn Therapeutics share in Mar 2026 is: 1.68.
In Mar, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 42.990% volatility is expected.
Pessimistic target level: 1.31
Optimistic target level: 2.29

Target values for the price of one Foghorn Therapeutics share for Apr 2026.

The weighted average target price per Foghorn Therapeutics share in Apr 2026 is: 2.07.
In Apr, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 29.824% volatility is expected.
Pessimistic target level: 1.67
Optimistic target level: 2.38

Target values for the price of one Foghorn Therapeutics share for May 2026.

The weighted average target price per Foghorn Therapeutics share in May 2026 is: 2.88.
In May, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 48.091% volatility is expected.
Pessimistic target level: 1.79
Optimistic target level: 3.46

Target values for the price of one Foghorn Therapeutics share for Jun 2026.

The weighted average target price per Foghorn Therapeutics share in Jun 2026 is: 3.11.
In Jun, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 42.997% volatility is expected.
Pessimistic target level: 2.30
Optimistic target level: 4.04

Target values for the price of one Foghorn Therapeutics share for Jul 2026.

The weighted average target price per Foghorn Therapeutics share in Jul 2026 is: 2.54.
In Jul, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 33.605% volatility is expected.
Pessimistic target level: 2.17
Optimistic target level: 3.26

Target values for the price of one Foghorn Therapeutics share for Aug 2026.

The weighted average target price per Foghorn Therapeutics share in Aug 2026 is: 3.57.
In Aug, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 49.697% volatility is expected.
Pessimistic target level: 2.47
Optimistic target level: 4.90

Target values for the price of one Foghorn Therapeutics share for Sep 2026.

The weighted average target price per Foghorn Therapeutics share in Sep 2026 is: 4.95.
In Sep, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 45.390% volatility is expected.
Pessimistic target level: 3.28
Optimistic target level: 6.00

Target values for the price of one Foghorn Therapeutics share for Oct 2026.

The weighted average target price per Foghorn Therapeutics share in Oct 2026 is: 2.93.
In Oct, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 31.022% volatility is expected.
Pessimistic target level: 2.29
Optimistic target level: 3.33

Target values for the price of one Foghorn Therapeutics share for Nov 2026.

The weighted average target price per Foghorn Therapeutics share in Nov 2026 is: 2.67.
In Nov, the Negative dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 22.655% volatility is expected.
Pessimistic target level: 2.35
Optimistic target level: 3.04

Target values for the price of one Foghorn Therapeutics share for Dec 2026.

The weighted average target price per Foghorn Therapeutics share in Dec 2026 is: 2.98.
In Dec, the Positive dynamics for Foghorn Therapeutics Inc. shares will prevail with possible monthly volatility of 37.388% volatility is expected.
Pessimistic target level: 2.25
Optimistic target level: 3.59



Related stocks from Healthcare sector


Disclaimer:

All forecast data on the site are provided for informational purposes of using neural forecasting tools in the financial market and are not a call to action and, moreover, are not trading signals. When using the forecast data, the investor assumes all financial risks. The pandaforecast.com portal is not responsible for the loss of your money in the stock market as a result of using the information contained on the site.